A detailed breakdown of Q3 FY26 pharma results covering Cipla, Dr Reddy’s Laboratories and Laurus Labs with key factors, CMP, fundamentals, technical view and management commentary.
A complete Indian stock market weekly view for Jan 27–Jan 30, 2026 with Nifty 50, Bank Nifty and Sensex levels, weekly range forecast, FII/DII overview, OI/PCR checklist, IPO updates, commodity and currency cues, plus short- and long-term investing plan.
India’s Union Budget 2026 is around the corner. This detailed pre-budget forecast covers market outlook, sector-wise expectations, stocks in focus, historical trends, and how retail investors should position with a risk-managed approach.
Pre-Budget Market Outlook (Union Budget 2026-27) — What the Market Is Pricing In Read More »
Indian stock market post market report for 23 January 2026 with Nifty 50, Sensex and Bank Nifty closing levels, reasons for market fall, top gainers and losers, sectors, VIX, FII DII data, IPO updates and outlook.
Today’s Indian stock market pre market report (Jan 23, 2026) covers global cues, GIFT Nifty, key index levels, support/resistance, VIX, PCR, FII/DII flows, IPO updates, commodities, USD/INR, and a practical trade checklist.
Indian Markets Pre Market Report (January 23, 2026) — Cautiously Positive Start Likely Read More »
Indian markets ended higher on 22 January 2026 as Nifty 50, Sensex and Bank Nifty snapped a three-day losing streak. This post-market report covers closing levels, reasons for the move, top gainers and losers, sectoral trends, Q3 results impact, FII DII data, VIX, IPO updates, commodities and a clear short-term and long-term market outlook.
